Patent · US Expired

(+)-6-chloro-5,10-dihy dro-5-[(1-methyl-4-piperidinyl)-acetyl]-11H-dibenzo[b,][1,4]diazepin-11-o ne, the isolation thereof and its use as a pharmaceutical material

US4668674A · kind A · utility

3Cited by

1References

5Claims

0Family size

Assignee

Dr. Karl Thomae GmbH · DE

Inventors

G/u/ nter Trummlitz · Warthausen, DE
Wolfhard Engel
Wolfgang Eberlein · Biberach, DE
Gerhard Mihm · Biberach, DE
Antonio Giachetti · Marsala, IT

Key dates

Filing date	Aug 19, 1986
Grant date	May 26, 1987
Priority date	—
Expiry date	Aug 19, 2006

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

There are described (+)-6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl)-acetyl]-11H-dibenzo [b,e][1,4]diazepin-11-one, the isolation thereof from a mixture of enantiomers and its use as a pharmaceutical material. The compound is characterized by a powerful activity against ulcers of the gastro-intestinal tract.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.